MERCK KGAA (MRK.DE) Stock Price, Forecast & Analysis
Europe - Frankfurt Stock Exchange - FRA:MRK - DE0006599905 - Common Stock
MRK.DE Key Statistics, Chart & Performance
The current stock price of MRK.DE is 112.3 EUR. In the past month the price decreased by -2.39%. In the past year, price decreased by -20.78%.
MRK.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 1SAN.MI | SANOFI | 11.54 | 213.66B | ||
| SAN.PA | SANOFI | 11.36 | 210.27B | ||
| SNW.DE | SANOFI | 11.35 | 209.50B | ||
| UCB.BR | UCB SA | 36.29 | 45.32B | ||
| UNC.DE | UCB SA | 34.83 | 43.49B | ||
| BAYN.DE | BAYER AG-REG | 5.17 | 27.10B | ||
| 1BAYN.MI | BAYER AG-REG | 5.15 | 27.01B | ||
| IPN.PA | IPSEN | 12.38 | 10.65B | ||
| REC.MI | RECORDATI INDUSTRIA CHIMICA | 25.76 | 10.61B | ||
| 1JAZZ.MI | JAZZ PHARMACEUTICALS PLC | 21.74 | 9.34B | ||
| TUB.BR | FINANCIERE DE TUBIZE | 96.63 | 8.95B | ||
| VIRP.PA | VIRBAC SA | 20.56 | 2.99B |
Related stock screener links
About MRK.DE
Company Profile
Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. The company is headquartered in Darmstadt, Hessen and currently employs 63,160 full-time employees. The firm operates in three business segments: Healthcare, Life Sciences and Electronics. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and neurodegenerative diseases, developing drugs, diagnostic substances and medical devices. The Life Sciences business comprises the activities of MilliporeSigma, which provides solutions that facilitate biotechnology and pharmaceutical research. The product range includes laboratory water systems, gene editing tools, cell lines and end-to-end drug manufacturing systems, among others. The Electronics business enables digital living and provides specialty chemicals for various applications, including liquid crystals for electronic displays, materials for integrated circuits, effect pigments for coatings and color cosmetics, as well as functional materials for energy solutions.
Company Info
MERCK KGAA
Frankfurter Strasse 250
Darmstadt HESSEN DE
Employees: 59020
Phone: 496151720
MERCK KGAA / MRK.DE FAQ
What does MRK do?
Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. The company is headquartered in Darmstadt, Hessen and currently employs 63,160 full-time employees. The firm operates in three business segments: Healthcare, Life Sciences and Electronics. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and neurodegenerative diseases, developing drugs, diagnostic substances and medical devices. The Life Sciences business comprises the activities of MilliporeSigma, which provides solutions that facilitate biotechnology and pharmaceutical research. The product range includes laboratory water systems, gene editing tools, cell lines and end-to-end drug manufacturing systems, among others. The Electronics business enables digital living and provides specialty chemicals for various applications, including liquid crystals for electronic displays, materials for integrated circuits, effect pigments for coatings and color cosmetics, as well as functional materials for energy solutions.
What is the stock price of MERCK KGAA today?
The current stock price of MRK.DE is 112.3 EUR. The price increased by 1.54% in the last trading session.
What is the dividend status of MERCK KGAA?
MERCK KGAA (MRK.DE) has a dividend yield of 1.99%. The yearly dividend amount is currently 0.65.
What is the ChartMill technical and fundamental rating of MRK stock?
MRK.DE has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 4 out of 10.
What is the analyst forecast for MRK.DE stock?
24 analysts have analysed MRK.DE and the average price target is 145.8 EUR. This implies a price increase of 29.83% is expected in the next year compared to the current price of 112.3.
Should I buy MRK stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on MRK.DE.
MRK.DE Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to MRK.DE. When comparing the yearly performance of all stocks, MRK.DE is a bad performer in the overall market: 84.48% of all stocks are doing better.
MRK.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to MRK.DE. MRK.DE has only an average score on both its financial health and profitability.
MRK.DE Financial Highlights
Over the last trailing twelve months MRK.DE reported a non-GAAP Earnings per Share(EPS) of 8.53. The EPS increased by 1.43% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 13.49% | ||
| ROA | 6.04% | ||
| ROE | 10.13% | ||
| Debt/Equity | 0.22 |
MRK.DE Forecast & Estimates
24 analysts have analysed MRK.DE and the average price target is 145.8 EUR. This implies a price increase of 29.83% is expected in the next year compared to the current price of 112.3.
For the next year, analysts expect an EPS growth of -1.79% and a revenue growth 0.28% for MRK.DE